To further investigate the poor survival in patients with low EZH2 mRNA expression, we compared protein expression in a set of matched diagnosis and relapse pairs of ten AML patients without EZH2 mutations (Supplementary Table 2). The gene discussed is EZH2; the disease is acute myeloid leukemia.